What is the action of selective serotonin reuptake inhibitors (SSRIs) in managing PMS symptoms?

• A. They increase serotonin levels
• B. They block progesterone receptors
• C. They suppress endometrial growth
• D. They enhance dopamine levels

Answer: (A)

Selective serotonin reuptake inhibitors (SSRIs) are known for their role in managing various mood disorders, and their action in the context of premenstrual syndrome (PMS) is primarily linked to their ability to increase serotonin levels in the brain. By inhibiting the reuptake of serotonin, SSRIs effectively boost the availability of this neurotransmitter within the synaptic cleft, leading to improved mood regulation and alleviation of depressive symptoms commonly associated with PMS.

The increase in serotonin levels can help in reducing irritability, anxiety, and mood swings that many individuals experience during the premenstrual phase. This mechanism of action highlights the importance of serotonin in emotional and behavioral regulation, making SSRIs a valuable option for managing symptomatic relief in patients suffering from PMS.

Other options, such as blocking progesterone receptors, suppressing endometrial growth, or enhancing dopamine levels, do not accurately reflect the primary pharmacological action of SSRIs, reinforcing why the correct choice is centered around serotonin levels.